Biomechanical assessment of fully bioresorbable devices.

The use of bioresorbable technologies for the treatment of coronary artery disease is a novel approach with potential advantages over the use of metal stents [(1)][1]. Several devices have undergone First-In-Man studies; however, the Absorb bioresorbable vascular scaffold (BVS) (Abbott Vascular,